State Street’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Buy |
51,084
+7,360
| +17% | +$24K | ﹤0.01% | 3881 |
|
|
2025
Q1 | $89.6K | Buy |
43,724
+27,000
| +161% | +$55.4K | ﹤0.01% | 3994 |
|
|
2024
Q4 | $36.8K | Hold |
16,724
| – | – | ﹤0.01% | 4156 |
|
|
2024
Q3 | $28.3K | Hold |
16,724
| – | – | ﹤0.01% | 4183 |
|
|
2024
Q2 | $40.8K | Buy |
16,724
+5,300
| +46% | +$12.9K | ﹤0.01% | 4176 |
|
|
2024
Q1 | $53.9K | Hold |
11,424
| – | – | ﹤0.01% | 4145 |
|
|
2023
Q4 | $52.6K | Hold |
11,424
| – | – | ﹤0.01% | 4189 |
|
|
2023
Q3 | $29.7K | Hold |
11,424
| – | – | ﹤0.01% | 4382 |
|
|
2023
Q2 | $55.2K | Hold |
11,424
| – | – | ﹤0.01% | 4395 |
|
|
2023
Q1 | $75.3K | Hold |
11,424
| – | – | ﹤0.01% | 4402 |
|
|
2022
Q4 | $127K | Hold |
11,424
| – | – | ﹤0.01% | 4292 |
|
|
2022
Q3 | $85K | Hold |
11,424
| – | – | ﹤0.01% | 4520 |
|
|
2022
Q2 | $69K | Hold |
11,424
| – | – | ﹤0.01% | 4655 |
|
|
2022
Q1 | $280K | Buy |
11,424
+10,394
| +1,009% | +$255K | ﹤0.01% | 4266 |
|
|
2021
Q4 | $49K | Buy |
+1,030
| New | +$49K | ﹤0.01% | 4704 |
|